Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Medtronic
Johnson and Johnson
Colorcon
AstraZeneca

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

NOCTIVA Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Noctiva patents expire, and when can generic versions of Noctiva launch?

Noctiva is a drug marketed by Alyvant and is included in one NDA. There are four patents protecting this drug.

This drug has one hundred and one patent family members in thirty countries.

The generic ingredient in NOCTIVA is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Drug patent expirations by year for NOCTIVA
Drug Prices for NOCTIVA

See drug prices for NOCTIVA

Recent Litigation for NOCTIVA

Identify potential future generic entrants

District Court Litigation
Case NameDate
Ferring B v. v. Allergan Inc.2012-04-05

See all NOCTIVA litigation

Synonyms for NOCTIVA
[deamino-Cys1,D-Arg8]vasopressin
[deamino-Cys1]AVP
[deamino1]AVP
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide
1-deamino,D-AVP
1-Desamino-8-arginine Vasopressin
1-Desamino-8-D-arginine vasopressin
6917-99-3
A810770
AC1L1EDS
AC1Q5JBY
Adiuretin
Adiuretin SD
BCP12604
BDBM85094
C06944
C4H10.CH2O
CAS_62357-86-2
CHEMBL264448
CS-1199
D00291
dAVP
DDAVP
Deamino Arginine Vasopressin
Deamino-8-D-arginine, l-, vasopressin
deamino-vasopressin
Desamino-8-D-arginine vasopressin, l-
Desmopresina [INN-Spanish]
DESMOPRESSIN
Desmopressin (INN)
Desmopressin [INN:BAN]
Desmopressin Monoacetate, Trihydrate
Desmopressine [INN-French]
Desmopressinum
Desmopressinum [INN-Latin]
desnopressin
EINECS 240-726-7
GTPL2181
GTPL2182
HY-17370A
L001026
LS-173612
LS-187262
Minirin
NSC_64759
SCHEMBL13575732
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
Vasopressin, Deamino Arginine

US Patents and Regulatory Information for NOCTIVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for NOCTIVA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3225249 CA 2019 00023 Denmark   Start Trial PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504
2712622 LUC00015 Luxembourg   Start Trial PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
3225249 2019C/520 Belgium   Start Trial PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513
3225249 300983 Netherlands   Start Trial PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513
2712622 122017000006 Germany   Start Trial PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Johnson and Johnson
AstraZeneca
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.